01—Abstract
Summary
Summary of the 8-K filed April 27, 2026. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) has announced an amendment to its 364-day multi-currency credit facility, effective April 22, 2026.
This amendment, designated as Amendment No. 11, modifies the existing $7 billiona facility, which has the potential to increase to $10 billion. The primary purpose of this credit facility is to provide temporary liquidity for CME's clearing house operations in specific, albeit unlikely, scenarios such as a clearing firm failing to meet its obligations, a liquidity constraint with a depositary, or disruptions in the domestic payment system impacting settlement variations.
02—Key points
Key Highlights
- CME Group Inc. amended its 364-day multi-currency credit facility on April 22, 2026.
- The credit facility has a base amount of $7 billion, with an option to increase it to $10 billion.
- The facility is designed to provide temporary liquidity to support CME's clearing house operations.
- Potential uses of the facility include covering clearing firm obligations, depositary liquidity issues, or payment system disruptions.
- The credit facility is secured by cash or U.S. Treasury securities contributed as clearing firm guaranty fund contributions, and performance bond assets.
- CME Group Inc. must maintain compliance with a consolidated tangible net worth test as per the facility's terms.
03—Questions
Frequently Asked Questions
What is the primary purpose of this amended credit facility?
The primary purpose of the amended credit facility is to provide temporary liquidity for CME's clearing house operations in specific, unlikely scenarios. These include a clearing firm failing to meet its obligations, issues with depositary liquidity for collateral, or disruptions in the domestic payment system that could delay settlement payments.
What is the total amount of the credit facility, and can it be increased?
The credit facility has an initial amount of $7 billion and is eligible to be increased to $10 billion.
What assets are used to collateralize this credit facility?
The facility can be collateralized by cash or U.S. Treasury securities received as clearing firm guaranty fund contributions, as well as performance bond assets held by CME.
Are there any financial covenants associated with this credit facility?
Yes, the credit facility includes a requirement for CME Group Inc. to remain in compliance with a consolidated tangible net worth test.
04—Continue